Medgenics Inc Directors Dealings (1777T)
15 11월 2013 - 10:35PM
UK Regulatory
TIDMMEDG TIDMMEDU
RNS Number : 1777T
Medgenics Inc
15 November 2013
Press Release 15 November 2013
Directors Dealings
Medgenics, Inc. (AIM: MEDU, MEDG and NYSE MKT: MDGN), the
developer of Biopump(TM) , a novel technology for the sustained
production and delivery of therapeutic proteins in patients using
their own tissue, announces that, on 11 November 2013 it was
informed by Dr. Sol Barer, Chairman of the Board of Directors of
the Company, that he purchased on the open market 25,000 shares of
common stock on that day at an average price of $6.8049 per
share.
Following this purchase, Dr. Barer now owns 72,000 shares of
common stock, which represents approximately 0.4 percent of the
total issued shares of common stock. Dr. Barer, directly or through
trusts for the benefit of Dr. Barer and his family, also has the
right to purchase up to 1,315,000 shares of common stock pursuant
to options previously granted (in aggregate Dr. Barer's shares of
common stock and options represent 1,387,000 shares of common stock
which represent approximately 7.5 percent of the Company's total
issued shares of common stock).
This announcement is being made pursuant to the London Stock
Exchange's AIM Rules for Companies admitted to trading on the AIM
market.
About Medgenics
Medgenics is developing and commercializing Biopump(TM), a
proprietary tissue-based platform technology for the sustained
production and delivery of therapeutic proteins using the patient's
own tissue for the treatment of a range of chronic diseases
including anemia, hepatitis, among others. For more information,
please visit www.medgenics.com.
Contacts:
Medgenics, Inc.
John Leaman, CFO
john.leaman@medgenics.com
Abchurch Communications
Joanne Shears / Jamie Hooper
/ Harriet Rae
harriet.rae@abchurch-group.com +44 207 398 7718
Oriel Securities (NOMAD & Joint
Broker)
Jonathan Senior / Giles Balleny +44 207 710 7617
SVS Securities plc (Joint Broker)
Alex Brearley +44 203 700 0100
-Ends-
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSUVUOROBAAAAA
Medgenics(Regs) (LSE:MEDG)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Medgenics(Regs) (LSE:MEDG)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024